These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 26989953)
1. Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye. Akiyama-Fukuda R; Usui T; Yoshida T; Yamagami S Cornea; 2016 May; 35(5):654-8. PubMed ID: 26989953 [TBL] [Abstract][Full Text] [Related]
2. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study. Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation. Carracedo G; Pastrana C; Serramito M; Rodriguez-Pomar C Acta Ophthalmol; 2019 Mar; 97(2):e162-e169. PubMed ID: 30280515 [TBL] [Abstract][Full Text] [Related]
4. Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation. Nagahara Y; Koh S; Maeda N; Nishida K; Watanabe H Eye Contact Lens; 2015 Sep; 41(5):318-22. PubMed ID: 25839348 [TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in the lower tear meniscus after instillation of artificial tears. Wang Y; Zhuang H; Xu J; Wang X; Jiang C; Sun X Cornea; 2010 Apr; 29(4):404-8. PubMed ID: 20164745 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery. Baek J; Doh SH; Chung SK Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809 [TBL] [Abstract][Full Text] [Related]
7. Diquafosol Ophthalmic Solution Increases Pre- and Postlens Tear Film During Contact Lens Wear in Rabbit Eyes. Nagahara Y; Koh S; Oshita Y; Nagano T; Mano H; Nishida K; Watanabe H Eye Contact Lens; 2017 Nov; 43(6):378-382. PubMed ID: 27243352 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Dry Eye by Tear Meniscus Measurements Using Anterior Segment Swept Source Optical Coherence Tomography. Akiyama R; Usui T; Yamagami S Cornea; 2015 Nov; 34 Suppl 11():S115-20. PubMed ID: 26448168 [TBL] [Abstract][Full Text] [Related]
9. The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study. Yokoi N; Kato H; Kinoshita S Eye (Lond); 2016 Jun; 30(6):857-64. PubMed ID: 27055679 [TBL] [Abstract][Full Text] [Related]
10. Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes. Yokoi N; Kato H; Kinoshita S Am J Ophthalmol; 2014 Jan; 157(1):85-92.e1. PubMed ID: 24200231 [TBL] [Abstract][Full Text] [Related]
11. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Park DH; Chung JK; Seo DR; Lee SJ Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791 [TBL] [Abstract][Full Text] [Related]
12. Immediate Effects of 3% Diquafosol and 0.1% Hyaluronic Acid Ophthalmic Solution on Tear Break-Up Time in Normal Human Eyes. Nam KT; Ahn SM; Eom Y; Kim HM; Song JS J Ocul Pharmacol Ther; 2015 Dec; 31(10):631-5. PubMed ID: 26630617 [TBL] [Abstract][Full Text] [Related]
13. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals. Utsunomiya T; Kawahara A; Hanada K; Yoshida A Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084 [TBL] [Abstract][Full Text] [Related]
14. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N; Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326 [TBL] [Abstract][Full Text] [Related]
15. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition. Shigeyasu C; Yamada M; Akune Y; Tsubota K Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103 [TBL] [Abstract][Full Text] [Related]
16. Influence of Ophthalmic Solutions on Tear Components. Shigeyasu C; Yamada M; Akune Y Cornea; 2016 Nov; 35 Suppl 1():S71-S77. PubMed ID: 27661071 [TBL] [Abstract][Full Text] [Related]
18. Serial measurement of tear meniscus by FD-OCT after instillation of artificial tears in patients with dry eyes. Bujak MC; Yiu S; Zhang X; Li Y; Huang D Ophthalmic Surg Lasers Imaging; 2011; 42(4):308-13. PubMed ID: 21800803 [TBL] [Abstract][Full Text] [Related]
19. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome. Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526 [TBL] [Abstract][Full Text] [Related]
20. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models. Choi KE; Song JS; Kang B; Eom Y; Kim HM Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]